UnitedHealth Group Incorporated faces challenges amidst DOJ investigations and margin pressures. Click for my UNH earnings ...

ClearBridge Investments, an investment management company, released its “ClearBridge Large Cap Growth Strategy” second quarter 2025 investor letter. A copy of the letter can be downloaded here.

Fundamentals Overall, UNH is a solid company. While it has only small gross profit margins of 21.99%, its EBITDA margin of 8.16% and strong ROE of 24.33% are far above the industry average.

UnitedHealth's shares drop 40% in 2025 amid challenges, with mixed Q1 earnings and margin pressures ahead. Read why I rate ...

Introduction UnitedHealth Group (NYSE: UNH) recently crashed after the U.S. Department of Justice might start a criminal investigation into the company. While this is a risk for investors, it is also ...

UnitedHealth Group stock declined on Wednesday following a report from the Wall Street Journal that ex-employees and medical ...

UnitedHealth is scheduled to report its Q2 earnings on July 29th. Jim Cramer recommends against buying UNH shares until then.

UnitedHealth Group (NYSE: UNH) has spent a significant amount of time in the sick bay for the first half of 2025, but it’s ...

Wall Street is cheering fresh highs as the S&P 500 Index ($SPX) wraps a solid second quarter, closing June 2025 strong. The ...